• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管使用肌苷治疗的亚急性硬化性全脑炎临床症状有所改善,但CT异常仍在进展。

Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.

作者信息

Noetzel M J, Dodson W E

出版信息

Ann Neurol. 1983 Apr;13(4):457-60. doi: 10.1002/ana.410130416.

DOI:10.1002/ana.410130416
PMID:6188412
Abstract

Inosiplex has been utilized in the treatment of subacute sclerosing panencephalitis (SSPE), though without unequivocally established beneficial effect. We report a patient whose computerized tomographic (CT) scans demonstrated the development of progressive cerebral atrophy and multifocal white matter lesions despite continuous treatment with inosiplex and periods of considerable clinical improvement or stabilization. The findings suggest that inosiplex may not have altered the pathological consequences of SSPE and that clinical staging categories alone may not be reliable long-term correlates of the progression of the disease. Controlled studies utilizing assessment of brain mass by CT scan or other imaging devices in addition to clinical staging are required to evaluate the efficacy of inosiplex.

摘要

肌苷已被用于治疗亚急性硬化性全脑炎(SSPE),尽管其有益效果尚未明确确立。我们报告了一名患者,尽管持续使用肌苷治疗且有相当长一段时间临床症状改善或稳定,但计算机断层扫描(CT)显示其出现了进行性脑萎缩和多灶性白质病变。这些发现表明,肌苷可能并未改变SSPE的病理后果,而且仅靠临床分期类别可能无法可靠地长期反映疾病的进展情况。需要进行对照研究,除了临床分期外,还利用CT扫描或其他成像设备评估脑容量,以评估肌苷的疗效。

相似文献

1
Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.尽管使用肌苷治疗的亚急性硬化性全脑炎临床症状有所改善,但CT异常仍在进展。
Ann Neurol. 1983 Apr;13(4):457-60. doi: 10.1002/ana.410130416.
2
Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.用肌苷治疗的亚急性硬化性全脑炎患者的长期随访
Ann Neurol. 1982 Apr;11(4):359-64. doi: 10.1002/ana.410110407.
3
The effect of inosiplex on the survival of subacute sclerosing panencephalitis.肌苷对亚急性硬化性全脑炎存活情况的影响。
Neurology. 1983 Aug;33(8):1053-5. doi: 10.1212/wnl.33.8.1053.
4
Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.肌苷治疗亚急性硬化性全脑炎。一项针对98例患者的多中心、非随机研究。
Lancet. 1982 May 8;1(8280):1034-7. doi: 10.1016/s0140-6736(82)92097-9.
5
The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.肌苷治疗对亚急性硬化性全脑炎患者神经功能障碍的影响。
J Pediatr. 1982 Aug;101(2):288-93. doi: 10.1016/s0022-3476(82)80143-1.
6
[The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].[肌苷片在亚急性硬化性全脑炎(SSPE)中的作用]
No To Hattatsu. 1984 Jul;16(4):262-70.
7
Inosiplex for SSPE.肌苷治疗亚急性硬化性全脑炎。
Lancet. 1982 Jun 26;1(8287):1475. doi: 10.1016/s0140-6736(82)92488-6.
8
Inosiplex for SSPE.肌苷多聚磷酸酯用于亚急性硬化性全脑炎
Lancet. 1982 Aug 28;2(8296):495. doi: 10.1016/s0140-6736(82)90521-9.
9
Inosiplex in the treatment of subacute sclerosing panencephalitis.肌苷治疗亚急性硬化性全脑炎
Arch Neurol. 1979 Jun;36(6):374-5. doi: 10.1001/archneur.1979.00500420084012.
10
Treatment of subacute sclerosing panencephalitis: an overview.亚急性硬化性全脑炎的治疗:综述
Drug Intell Clin Pharm. 1984 May;18(5):375-81. doi: 10.1177/106002808401800503.

引用本文的文献

1
Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.肌苷普乐安:对抗多种病毒感染和非传染性疾病的关键药物。
Adv Ther. 2019 Aug;36(8):1878-1905. doi: 10.1007/s12325-019-00995-6. Epub 2019 Jun 5.
2
Regional cerebral metabolic rate for glucose in subacute sclerosing panencephalitis.亚急性硬化性全脑炎的局部脑葡萄糖代谢率
Eur J Pediatr. 1987 May;146(3):288-9. doi: 10.1007/BF00716475.
3
Intraventricular interferon in a case of subacute sclerosing panencephalitis.亚急性硬化性全脑炎病例中的脑室内干扰素
Ital J Neurol Sci. 1987 Jun;8(3):277-81. doi: 10.1007/BF02337487.
4
Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.异丙肌苷。对其药效学、药代动力学特性及治疗效果的初步综述。
Drugs. 1986 Nov;32(5):383-424. doi: 10.2165/00003495-198632050-00001.